Expression of Vascular Endothelial Growth Factor in Patients With Premalignant Lesions and Squamous Cell Carcinoma of Oral Cavity

Overview

Journal Indian J Otolaryngol Head Neck Surg

Publisher Springer

Date 2022 Dec 1

PMID 36452814

Authors

Ashish Agarwal

Shalini Jain

Nishi Sharma

Affiliations

Soon will be listed here.

Abstract

To evaluate and compare expression of VEGF in patients of premalignant lesions and squamous cell carcinoma of oral cavity. The cross sectional observational study is undertaken at the department of otorhionolaryngology and pathology, PGIMER and Dr RML Hospital, New Delhi,from 1st Nov 2017 to 31st March 2019,with a sample size of 30 cases each of premalignant lesions and oral squamous cell carcinoma immunohistochemistry by polymer method. In the participants with oral SCC, VEGF expression of Score 1 was observed in verrucous and well differentiated tumor, Score 2 in moderately differentiated SCC & Score 3 in poorly differentiated SCC with a value of 0.0001. The observed difference and value of proportion p, is statically significant. In this study we concluded that VEGF expression increases as the lesion progresses from premalignant lesions to oral squamous cell carcinoma and is strongly associated with lymph node status (N-staging). Thus, VEGF can be a target in chemotherapy and its therapeutic implications in the HNSCC needs further research. 1A: Systematic review of randomized control trials.

References

Carlile J, Harada K, Baillie R, Macluskey M, Chisholm D, Ogden G . Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med. 2001; 30(8):449-57. DOI: 10.1034/j.1600-0714.2001.030008449.x. View

Farhi D, Dupin N . Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2010; 28(1):100-8. DOI: 10.1016/j.clindermatol.2009.03.004. View

Folkman J, Watson K, Ingber D, Hanahan D . Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989; 339(6219):58-61. DOI: 10.1038/339058a0. View

Roskoski Jr R . Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol. 2007; 62(3):179-213. DOI: 10.1016/j.critrevonc.2007.01.006. View

Neuchrist C, Erovic B, Handisurya A, Fischer M, Steiner G, Hollemann D . Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck. 2003; 25(6):464-74. DOI: 10.1002/hed.10235. View

Banoczy J, Gintner Z, Dombi C . Tobacco use and oral leukoplakia. J Dent Educ. 2001; 65(4):322-7. View

Strome S, To W, Strawderman M, Gersten K, Devaney K, Bradford C . Squamous cell carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg. 1999; 120(3):375-9. DOI: 10.1016/S0194-5998(99)70278-0. View

Folkman J . Angiogenesis-dependent diseases. Semin Oncol. 2001; 28(6):536-42. DOI: 10.1016/s0093-7754(01)90021-1. View

Sheelam S, Reddy S, Kulkarni P, Nandan S, Keerthi M, Raj G . Role of cell proliferation and vascularity in malignant transformation of potentially malignant disorders. J Oral Maxillofac Pathol. 2018; 22(2):281. PMC: 6097360. DOI: 10.4103/jomfp.JOMFP_182_17. View

10.

Penfold C, Partridge M, Rojas R, Langdon J . The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 1996; 34(1):37-41. DOI: 10.1016/s0266-4356(96)90133-3. View

11.

Underiner T, Ruggeri B, Gingrich D . Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. Curr Med Chem. 2004; 11(6):731-45. DOI: 10.2174/0929867043455756. View

12.

Sturgis E, Wei Q, Spitz M . Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004; 31(6):726-33. DOI: 10.1053/j.seminoncol.2004.09.013. View

13.

Pazouki S, Chisholm D, Adi M, Carmichael G, Farquharson M, Ogden G . The association between tumour progression and vascularity in the oral mucosa. J Pathol. 1997; 183(1):39-43. DOI: 10.1002/(SICI)1096-9896(199709)183:1<39::AID-PATH1088>3.0.CO;2-L. View

14.

van der Waal I . Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010; 46(6):423-5. DOI: 10.1016/j.oraloncology.2010.02.016. View

15.

Ferrara N, Henzel W . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989; 161(2):851-8. DOI: 10.1016/0006-291x(89)92678-8. View

16.

Connolly D . Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem. 1991; 47(3):219-23. DOI: 10.1002/jcb.240470306. View

17.

Marur S, Forastiere A . Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008; 83(4):489-501. DOI: 10.4065/83.4.489. View

18.

Kamangar F, Dores G, Anderson W . Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24(14):2137-50. DOI: 10.1200/JCO.2005.05.2308. View

19.

Acharya S, Sivakumar A, Shetty S . Cervical lymph node metastasis in oral squamous cell carcinoma: a correlative study between histopathological malignancy grading and lymph node metastasis. Indian J Dent Res. 2013; 24(5):599-604. DOI: 10.4103/0970-9290.123385. View

20.

Johnstone S, Logan R . Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2006; 36(3):263-6. DOI: 10.1016/j.ijom.2006.09.017. View